However, this cardiovascular disease benefit may be GLP1 mimetic specific, given that other trials using GLP1 mimetics with shorter halflives and lower homology to native GLP1, such as lixisenatide (ELIXSA) or exenatide (EXSCEL), failed to show a significant cardiovascular disease benefit (Holman et al., 2017)
In today's podcast, we're gonna talk about what's happening metabolically in perimenopause and menopause, and how changing hormones are influencing your metabolic health, and what is happening with visceral adiposity, so the fat that likes to pack around our organs
Some people taking Ozempic report unpleasant mouth odor, but Ozempic breath is a patient-coined term, not an official diagnosis, and it does not occur in everyone
Crossing boundaries: interplay between the immune system and oligodendrocyte lineage cells
Improved liver function, as a result of weight loss, can lead to more efficient uric acid processing and reduced levels in the blood